Episode Description (Description Box):
In today’s episode we are taking a deep dive into the firm’s Internship program featuring the 2023 Summer Analyst class as well as our newest Intern turned full-time employee. They will be giving you all the inside scoop on their experience at SWS.
About our Speakers:
Moderator: Audrey Chu, Associate West Coast Region
Melissa Rowe, Human Resources Director
Jessica Walton, Public Finance Analyst
2023 Summer Analyst Interns:
SUBSCRIBE to be notified of our future episodes and SHARE.
Stay connected with us!
Visit our website: www.siebertwilliams.com
Follow us on LinkedIn: https://www.linkedin.com/company/siebertwilliamsshank
This podcast should not be copied, distributed, published or reproduced, in whole or in part. The information contained in this recording is not a statement of Siebert Williams Shank & Co.’s policy. This podcast is not a product of SWS’s Investment Research and the information contained in this podcast is not financial research. The views and opinions expressed by guests are their own and their appearance on the program does not imply an endorsement or reflection of their views by SWS. and may differ from the views and opinions of other departments or divisions of SWS and its affiliates. SWS is not providing any financial, economic, legal, accounting, or tax advice or recommendations in this podcast. The information contained in this podcast does not constitute investment advice or an offer to buy or sell securities from any SWS entity to the listener and should not be relied upon to evaluate any potential transaction. In addition, the receipt of this podcast by any listener is not to be taken to constitute such person a client of any SWS entity. Neither SWS nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed.